Who
Kelly Gold
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, CAMP4 Therapeutics; Director, X4 Pharmaceuticals.
In numbers
- Trades disclosed
- 11
- Buys
- 3
- Sells
- 0
- Bought
- $111K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Apr 2025
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $40K10,000 at $3.96 | filing |
| 31 Aug 2026filed 2 Sep 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $40K10,000 at $3.96 | filing |
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 3 Aug 2026filed 5 Aug 2026 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $11K6,551 at $1.65 | filing |
| 1 Jul 2026filed 1 Jul 2026 | XFOR X4 Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | XFOR X4 Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —215,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —215,000 at $0.00 | filing |
| 11 Dec 2025filed 22 Dec 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | CAMP CAMP4 TherapeuticsBiotechnology | SEC FORM 4 Bought | $9,9996,060 at $1.65 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CAMP CAMP4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
News
Critical Analysis: Iovance Biotherapeutics (NASDAQ:IOVA) vs. CAMP4 Therapeutics (NASDAQ:CAMP)CAMP · tickerreport.com · 24 Oct 2026
0 headlines in the last 90 days name Kelly Gold; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.